Top cited articles
Acceptance Rate:
33%
Time to first decision with review:
35 days*
Acceptance to publication:
22 days*
Impact Factor:
3.7
Citescore:
5.3
Hydroxychloroquine in the pregnancies of women with lupus: a meta-analysis of individual participant data
Immunogenicity of the third and fourth BNT162b2 mRNA COVID-19 boosters and factors associated with immune response in patients with SLE and rheumatoid arthritis
Clinical and histopathological features of myositis in systemic lupus erythematosus
Severe flares are associated with a poorer health-related quality of life (HRQoL) in patients with SLE: data from the Almenara Lupus Cohort
Pregnancy outcomes in antiphospholipid antibody positive patients: prospective results from the AntiPhospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networking (APS ACTION) Clinical Database and Repository ('Registry')
Intermittent and Persistent Type 2 lupus: patient perspectives on two distinct patterns of Type 2 SLE symptoms
Adverse pregnancy outcomes in women with systemic lupus erythematosus: can we improve predictions with machine learning?
Glucocorticoid discontinuation in patients with SLE with prior severe organ involvement: a single-center retrospective analysis
Autoantibodies associated with systemic sclerosis in three autoimmune diseases imprinted by type I interferon gene dysregulation: a comparison across SLE, primary Sjogren's syndrome and systemic sclerosis
Type 1 interferon status in systemic lupus erythematosus: a longitudinal analysis
Conceptual framework for defining disease modification in systemic lupus erythematosus: a call for formal criteria
Association between systemic lupus erythematosus and disruption of gut microbiota: a meta-analysis
Metformin improves renal injury of MRL/lpr lupus-prone mice via the AMPK/STAT3 pathway
Risk factors of flare in patients with systemic lupus erythematosus after glucocorticoids withdrawal. A systematic review and meta-analysis
LLDAS (lupus low disease activity state) and/or remission are associated with less damage accrual in patients with systemic lupus erythematosus from a primarily Mestizo population: data from the Almenara Lupus Cohort
Real-world burden of systemic lupus erythematosus in the USA: a comparative cohort study from the Medical Expenditure Panel Survey (MEPS) 2016-2018
Interleukin (IL) 16: a candidate urinary biomarker for proliferative lupus nephritis
Medium-term impact of the SARS-CoV-2 mRNA vaccine against disease activity in patients with systemic lupus erythematosus
Gut microbiota in SLE: from animal models to clinical evidence and pharmacological perspectives
Transcription factor Fli-1 impacts the expression of CXCL13 and regulates immune cell infiltration into the kidney in MRL/lpr mouse
Generation of evidence supporting the content validity of SF-36, FACIT-F, and LupusQoL, and novel patient-reported symptom items for use in patients with systemic lupus erythematosus (SLE) and SLE with lupus nephritis (LN)